Longitudinal retinal layer changes in preclinical Alzheimer’s disease
Autor: | Mara ten Kate, Frank D. Verbraak, H. Stevie Tan, Adriaan A. Lammertsma, Dorret I. Boomsma, Pieter Jelle Visser, Anouk den Braber, Jori Tomassen, Jacoba A. van de Kreeke, Maqsood Yaqub, Bart N.M. van Berckel, Elles Konijnenberg, Hoang Ton Nguyen |
---|---|
Přispěvatelé: | Biological Psychology, APH - Mental Health, APH - Methodology, Ophthalmology, ACS - Diabetes & metabolism, Neurology, Amsterdam Neuroscience - Neurodegeneration, Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, AMS - Tissue Function & Regeneration, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Amsterdam Neuroscience - Systems & Network Neuroscience, Amsterdam Reproduction & Development (AR&D) |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty retina Disease ocular biomarkers 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Optical coherence tomography Retinal Diseases Alzheimer Disease Ophthalmology medicine preclinical Alzheimer’s disease Humans Aged Cerebral Cortex Retina Amyloid beta-Peptides medicine.diagnostic_test business.industry Binding potential Brain Retinal General Medicine Original Articles twins Inner plexiform layer medicine.anatomical_structure chemistry OCT Positron emission tomography Positron-Emission Tomography 030221 ophthalmology & optometry Biomarker (medicine) Original Article Female sense organs business 030217 neurology & neurosurgery Biomarkers Tomography Optical Coherence |
Zdroj: | Acta Ophthalmologica Acta Ophthalmologica, 99(5), 538-544. Wiley-Blackwell van de Kreeke, J A, Nguyen, H T, Konijnenberg, E, Tomassen, J, den Braber, A, ten Kate, M, Yaqub, M, van Berckel, B, Lammertsma, A A, Boomsma, D I, Tan, H S, Visser, P J & Verbraak, F D 2021, ' Longitudinal retinal layer changes in preclinical Alzheimer’s disease ', Acta Ophthalmologica, vol. 99, no. 5, pp. 538-544 . https://doi.org/10.1111/aos.14640 Van De Kreeke, J A, Nguyen, H T, Konijnenberg, E, Tomassen, J, den Braber, A, Kate, M, Yaqub, M, Berckel, B, Lammertsma, A A, Boomsma, D I, Tan, H S, Visser, P J & Verbraak, F D 2021, ' Longitudinal retinal layer changes in preclinical Alzheimer’s disease ', Acta Ophthalmologica, vol. 99, no. 5, pp. 538-544 . https://doi.org/10.1111/aos.14640 |
ISSN: | 1755-3768 1755-375X |
Popis: | Purpose: Several studies found reduced retinal thickness on optical coherence tomography (OCT) in Alzheimer’s disease (AD), even in preclinical stages, labelling this technique of interest as biomarker. In this study, we examine retinal thickness changes in preclinical AD, as defined by cognitively normal individuals with amyloid-beta (Aβ) on positron emission tomography (PET). Methods: For this monocentre study, 145 cognitively healthy monozygotic twins aged ≥ 60 were included from the Netherlands Twin Register taking part in the EMIF-AD PreclinAD study. At baseline, participants underwent [ 18F] flutemetamol PET that was visually rated for cortical Aβ. Binding potential was calculated as continuous measure for Aβ. Optical coherence tomography (OCT) was performed at baseline and after 22 months to assess changes in total and individual inner retinal layer thickness in the macular region (ETDRS circles) and peripapillary retinal nerve fibre layer thickness. Differences in rate of change between amyloid-beta positive and negative individuals and associations between binding potential and change in retinal thickness were evaluated. Results: Sixteen participants (11%) were positive for Aβ. Change in retinal thickness did not differ in any region between Aβ+ and Aβ− individuals. A positive association between binding potential and change in inner plexiform layer thickness was observed in the inner macular ring (beta = 1.708, CI = 0.575 to 2.841, p = 0.003). Conclusion: Aβ+ individuals did not differ in rate of change of any retinal layer compared to controls, but higher binding potential at baseline was associated with less IPL thinning over time. Optical coherence tomography (OCT) as a longitudinal screening tool for preclinical AD seems limited, but IPL changes offer leads for further research. |
Databáze: | OpenAIRE |
Externí odkaz: |